A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: The TARGET study
© 2017 The Author(s). Background: Tenofovir disoproxil fumarate (TDF) is key component of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) for HIV, but existing tools to monitor drug adherence are often inaccurate. Detection of tenofovir (TFV) in accessible biological samples, such a...
Saved in:
Main Authors: | Cressey T., Siriprakaisil O., Klinbuayaem V., Quame-Amaglo J., Kubiak R., Sukrakanchana P., Than-in-at K., Baeten J., Sirirungsi W., Cressey R., Drain P. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85023612304&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/40282 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: The TARGET study
by: Tim R. Cressey, et al.
Published: (2018) -
A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: The TARGET study
by: Tim R. Cressey, et al.
Published: (2018) -
Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care Test
by: Monica Gandhi, et al.
Published: (2019) -
Urine tenofovir concentrations correlate with plasma and relate to tenofovir disoproxil fumarate adherence: A randomized, directly observed pharmacokinetic trial (target study)
by: Paul K. Drain, et al.
Published: (2020) -
Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
by: Tim R. Cressey, et al.
Published: (2020)